title: Oral care for patients with cardiovascular disease and stroke.
abstract: BACKGROUND
  The authors describe how oral disease, particularly periodontal disease, may place certain patients at increased risk of developing cardiovascular disease and stroke.
  
  
  RESULTS
  Although the precise mechanisms of interaction are not clear, two biological mechanisms that may explain the relationship are presented. In addition, the authors describe the dental management issues that need to be understood in treating patients compromised by cardiovascular disease.
  
  
  CONCLUSIONS
  The patient with cardiovascular disease may present a challenge to the dental health care provider, depending on the degree of hemodynamic compromise and the stability of his or her condition.
authors.affiliation: MCP Hahnemann School of Medicine, University of Pennsylvania School of Dental Medicine, Philadelphia, USA. dentalteam@speakeasy.net
authors.forename: Louis F
authors.initials: LF
authors.lastname: Rose
authors.forename: Brian
authors.initials: B
authors.lastname: Mealey
authors.forename: Laura
authors.initials: L
authors.lastname: Minsk
authors.forename: D Walter
authors.initials: DW
authors.lastname: Cohen
mesh_terms: D000766:Anesthesia, Dental; D000787:Angina Pectoris; D000925:Anticoagulants / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac; D016470:Bacteremia / Q000150:complications; D002318:Cardiovascular Diseases / Q000209:etiology; D016207:Cytokines / Q000378:metabolism; D017742:Dental Care for Chronically Ill; D004697:Endocarditis, Bacterial / Q000209:etiology; D006349:Heart Valve Diseases; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism; D009203:Myocardial Infarction; D010518:Periodontitis / Q000150:complications; D020521:Stroke / Q000209:etiology; D014662:Vasoconstrictor Agents / Q000008:administration & dosage
chemical_list: D000925:Anticoagulants; D016207:Cytokines; D018836:Inflammation Mediators; D014662:Vasoconstrictor Agents